ATE127012T1 - Aerosole die arzneimittel enthalten. - Google Patents

Aerosole die arzneimittel enthalten.

Info

Publication number: ATE127012T1
Authority: AT; Austria
Prior art keywords: medicinal products; aerosols containing; containing medicinal; amino; benzenemethanol
Prior art date: 1990-11-09

Application number

AT91919478T

Other languages

English (en)

Inventor

Anthony James Taylor

Patricia Kwong Phieu Burnell

Park Road Limited

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-09

Filing date

1991-11-07

Publication date

1995-09-15

1991-11-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1995-09-15 Application granted granted Critical

1995-09-15 Publication of ATE127012T1 publication Critical patent/ATE127012T1/de

Links

239000000443 aerosol Substances 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
NUBLQEKABJXICM-UHFFFAOYSA-N 1-(4-amino-3,5-dichlorophenyl)-2-[6-(2-pyridin-2-ylethoxy)hexylamino]ethanol Chemical compound C1=C(Cl)C(N)=C(Cl)C=C1C(O)CNCCCCCCOCCC1=CC=CC=N1 NUBLQEKABJXICM-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 abstract 1
MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical class C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1
229960004017 salmeterol Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT91919478T 1990-11-09 1991-11-07 Aerosole die arzneimittel enthalten. ATE127012T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909024366A GB9024366D0 (en)	1990-11-09	1990-11-09	Medicaments

Publications (1)

Publication Number	Publication Date
ATE127012T1 true ATE127012T1 (de)	1995-09-15

Family

ID=10685110

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91919478T ATE127012T1 (de)	1990-11-09	1991-11-07	Aerosole die arzneimittel enthalten.

Country Status (11)

Country	Link
EP (1)	EP0556239B1 (de)
JP (1)	JP3468767B2 (de)
AT (1)	ATE127012T1 (de)
AU (1)	AU653369B2 (de)
CA (1)	CA2094727C (de)
DE (1)	DE69112635T2 (de)
DK (1)	DK0556239T3 (de)
ES (1)	ES2078550T3 (de)
GB (1)	GB9024366D0 (de)
GR (1)	GR3018171T3 (de)
WO (1)	WO1992008447A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9104650D0 (en) *	1991-03-05	1991-04-17	Glaxo Group Ltd	Medicaments
DE4123663A1 (de) *	1991-07-17	1993-01-21	Schwabe Willmar Gmbh & Co	Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5653962A (en) *	1991-12-12	1997-08-05	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicaments
US5744123A (en) *	1991-12-12	1998-04-28	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) *	1991-12-12	1998-04-07	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicament
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
CA2455115C (en)	1991-12-12	2008-05-27	Glaxo Group Limited	Pharmaceutical aerosol formulation
US5658549A (en) *	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
NZ246046A (en) *	1991-12-12	1995-12-21	Glaxo Group Ltd	Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
US5916540A (en)	1994-10-24	1999-06-29	Glaxo Group Limited	Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) *	1991-12-12	1997-10-07	Glaxo Group Limited	Aerosol formulations containing P134a and salbutamol
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
US5593661A (en) *	1993-03-29	1997-01-14	Henry; Richard A.	Lidocaine aerosol anaesthetic
DE4323636A1 (de) *	1993-07-15	1995-01-19	Hoechst Ag	Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
GB9322014D0 (en)	1993-10-26	1993-12-15	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
JPH09506097A (ja) *	1993-12-02	1997-06-17	アボツト・ラボラトリーズ	非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤
US5711934A (en) *	1994-04-11	1998-01-27	Abbott Laboratories	Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
GB9501841D0 (en)	1995-01-31	1995-03-22	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
US5635161A (en) *	1995-06-07	1997-06-03	Abbott Laboratories	Aerosol drug formulations containing vegetable oils
GB9515182D0 (en) *	1995-07-24	1995-09-20	Co Ordinated Drug Dev	Improvements in and relating to powders for use in dry powder inhalers
US6254882B1 (en)	1997-09-16	2001-07-03	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
GB9807232D0 (en)	1998-04-03	1998-06-03	Univ Cardiff	Aerosol composition
DK1169019T3 (da) *	1999-04-14	2003-06-02	Glaxo Group Ltd	Farmaceutisk aerosolformulering
DE60140268D1 (de)	2000-11-30	2009-12-03	Vectura Ltd	Partikel zur verwendung in einer pharmazeutischen zusammensetzung
GB0107106D0 (en) *	2001-03-21	2001-05-09	Boehringer Ingelheim Pharma	Powder inhaler formulations
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
GB0130703D0 (en) *	2001-12-21	2002-02-06	Glaxo Group Ltd	Particles
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
CA2524538A1 (en) *	2003-05-19	2004-12-02	Baxter International Inc.	Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
WO2008097664A1 (en)	2007-02-11	2008-08-14	Map Pharmaceuticals, Inc.	Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US8652443B2 (en)	2008-02-14	2014-02-18	Precision Dermatology, Inc.	Foamable microemulsion compositions for topical administration
TWI597072B (zh)	2011-10-11	2017-09-01	吉斯藥品公司	包覆脂肪酸的β－致效劑之結晶微粒
WO2018051133A1 (en)	2016-09-19	2018-03-22	Mexichem Fluor S.A. De C.V.	Pharmaceutical composition
GEP20217239B (en)	2016-09-19	2021-03-25	Mexichem Fluor Sa De Cv	Pharmaceutical composition
CN109715160A (zh)	2016-09-19	2019-05-03	墨西哥氟石股份公司	药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
IL97065A (en) *	1990-02-02	1994-01-25	Fisons Plc	Repellent preparations for aerosol
DE4003272A1 (de) *	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen

1990
- 1990-11-09 GB GB909024366A patent/GB9024366D0/en active Pending
1991
- 1991-11-07 ES ES91919478T patent/ES2078550T3/es not_active Expired - Lifetime
- 1991-11-07 DE DE69112635T patent/DE69112635T2/de not_active Expired - Lifetime
- 1991-11-07 WO PCT/GB1991/001961 patent/WO1992008447A1/en not_active Ceased
- 1991-11-07 AT AT91919478T patent/ATE127012T1/de not_active IP Right Cessation
- 1991-11-07 AU AU88629/91A patent/AU653369B2/en not_active Expired
- 1991-11-07 DK DK91919478.7T patent/DK0556239T3/da active
- 1991-11-07 JP JP51743291A patent/JP3468767B2/ja not_active Expired - Lifetime
- 1991-11-07 CA CA002094727A patent/CA2094727C/en not_active Expired - Lifetime
- 1991-11-07 EP EP91919478A patent/EP0556239B1/de not_active Expired - Lifetime
1995
- 1995-11-22 GR GR950403290T patent/GR3018171T3/el unknown

Also Published As

Publication number	Publication date
WO1992008447A1 (en)	1992-05-29
JPH06501693A (ja)	1994-02-24
EP0556239A1 (de)	1993-08-25
GR3018171T3 (en)	1996-02-29
EP0556239B1 (de)	1995-08-30
ES2078550T3 (es)	1995-12-16
AU8862991A (en)	1992-06-11
DK0556239T3 (da)	1995-11-06
CA2094727A1 (en)	1992-05-10
GB9024366D0 (en)	1991-01-02
AU653369B2 (en)	1994-09-29
DE69112635D1 (de)	1995-10-05
CA2094727C (en)	2002-01-15
JP3468767B2 (ja)	2003-11-17
DE69112635T2 (de)	1996-02-08

Legal Events

Date	Code	Title	Description
1996-04-15	UEP	Publication of translation of european patent specification
2012-02-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE127012T1 (de)	1995-09-15	Aerosole die arzneimittel enthalten.
ATE127013T1 (de)	1995-09-15	Aerosolzusammensetzungen.
YU59192A (sh)	1994-12-28	Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
GEP20002140B (en)	2000-06-25	Pharmaceutical Aerosol Composition
GB2263064B (en)	1994-09-14	Aerosol drug formulations
YU59092A (sh)	1994-12-28	Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
ATE366568T1 (de)	2007-08-15	Aerosolformulierungen von salmeterol xinafoate
FI90014B (fi)	1993-09-15	Foerfarande foer loesning av ett laekemedel som loeser sig daoligt i klorfluorkolvaete-aerosoldrivmedel
ES2189410T3 (es)	2003-07-01	Formulacion farmaceutica en aerosol.
AR002009A1 (es)	1998-01-07	Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
AU663299B2 (en)	1995-10-05	Flexible bag for packaging compressed products
NZ240237A (en)	1994-06-27	An aerosol formulation (free of surfactant) for treatment of asthma comprising: a hydrofluorocarbon propellant, ethanol, and beclomethasone 17,21 dipropionate; preparation thereof
HRP20010343B1 (hr)	2010-11-30	Farmaceutski pripravak za modificirano otpuštanje senzitizatora za inzulin i drugog antidijabetičkog sredstva
MX9704545A (es)	1997-10-31	Formulaciones en aerosol de peptidos y proteinas.
NO305028B1 (no)	1999-03-22	AnalogifremgangsmÕte for fremstilling av terapeutisk aktive pyridin N-oxydderivater av diarylmethylpiperidiner eller piperaziner
FI963424A0 (fi)	1996-09-02	Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
CA2206782A1 (en)	1996-06-27	Aerosol drug formulations
CA2311450A1 (en)	1999-06-17	Pharmaceutical aerosol compositions
ATE85757T1 (de)	1993-03-15	Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
DK0443848T3 (da)	1994-10-17	Nyt antiulcermiddel
GR3017949T3 (en)	1996-02-29	Lateral edge coated controlled release pharmaceutical compositions.
MY106672A (en)	1995-07-31	Dichloroaniline compound.
ZA81473B (en)	1982-03-31	5-amino-tetayole derivatives of retinoic acids, their preparation and pharmaceutical formulations containg these derivatives
EP1245562A4 (de)	2004-12-15	5-thia-"omega"-(substituiertes phenyl)-prostaglandin e alkohole, verfahren zur herstellung der alkohole und pharmzeutische zusammensetzungen, die diese als aktive inhaltsstoffe enthalten
IT8919370A0 (it)	1989-02-09	Metodo per ridurre gli effetti irritativi locali di preparazione farmaceutiche e composizioni cosi' ottenute.